← Back to Clinical Trials
Recruiting NCT07695675

NCT07695675 Community Dining, Walking, and Glucose in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07695675
Status Recruiting
Phase —
Sponsor Yang Zhang
Condition Prediabetes
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2026-08-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age 79 Years
Study Type INTERVENTIONAL
Interventions
Subsidized Community DiningHome Eating

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 15 participants in total. It began in 2026-08-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will examine whether eating lunch and dinner at a subsidized community dining site affects postmeal walking and blood glucose patterns in older adults. Participants will be community-dwelling adults aged 60 to 79 years who are eligible for a local elderly meal subsidy and have prediabetes or elevated blood glucose risk. Each participant will complete two 6-day meal conditions in random order. In one condition, participants will eat lunch and dinner at home. In the other condition, participants will eat lunch and dinner at a subsidized community dining site. Participants will wear a continuous glucose monitor and an activity tracker so the study team can measure postmeal glucose levels, daily glucose patterns, and steps after meals. The study will compare community dining with home eating to determine whether community dining increases postmeal walking, improves postmeal glucose responses, and affects loneliness and meal experience.

Eligibility Criteria

Inclusion Criteria: * Community-dwelling adults aged 60 to 79 years * Eligible for the local elderly meal subsidy * Prediabetes or elevated glycemic risk, defined as HbA1c 5.7% to 6.4% or fasting plasma glucose 100 to 125 mg/dL * Able to consume meals orally * Able to walk independently without a walking aid * Able to attend the community dining site safely * Able and willing to wear a continuous glucose monitor and activity tracker * Able and willing to follow the home-meal plan and study procedures * Able to provide written informed consent Exclusion Criteria: * HbA1c ≥6.5% or fasting plasma glucose ≥126 mg/dL * Diagnosed diabetes * Use of insulin or glucose-lowering medication * Severe cognitive impairment * Acute illness or recent hospitalization * Severe gastrointestinal disease affecting usual food intake or gastric emptying * Severe renal, hepatic, cardiovascular, or neurologic disease that would make participation unsafe * Skin conditions preventing continuous glucose monitor use * Food allergy or dietary restrictions incompatible with the standardized meal plan

Contact & Investigator

Central Contact

Meng-Qi Zhen, MA

✉ 53221639@qq.com

📞 8618867413605

Principal Investigator

Yang Zhang, PhD

STUDY CHAIR

Frequently Asked Questions

Who can join the NCT07695675 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, up to 79 Years, studying Prediabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07695675 currently recruiting?

Yes, NCT07695675 is actively recruiting participants. Contact the research team at 53221639@qq.com for enrollment information.

Where is the NCT07695675 trial being conducted?

This trial is being conducted at Changsha, China.

Who is sponsoring the NCT07695675 clinical trial?

NCT07695675 is sponsored by Yang Zhang. The principal investigator is Yang Zhang, PhD. The trial plans to enroll 15 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology